One Of Two Pfizer Lipitor Patents Upheld By U.K. Court
This article was originally published in The Pink Sheet Daily
Executive Summary
The company says the British court’s ruling, which could keep Ranbaxy’s generic off the market until 2011, “has no bearing” on atorvastatin patent litigation in the U.S.